Cargando…

Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels

Butyrate exerts protective effects against non-alcoholic steatohepatitis (NASH), but the underlying mechanisms are unclear. We aimed to investigate the role of butyrate-induced gut microbiota and metabolism in NASH development. Sixty-five C57BL/6J mice were divided into four groups (n = 15–17 per gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Jianzhong, Lv, Longxian, Wu, Wenrui, Li, Yating, Shi, Ding, Fang, Daiqiong, Guo, Feifei, Jiang, Huiyong, Yan, Ren, Ye, Wanchun, Li, Lanjuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111843/
https://www.ncbi.nlm.nih.gov/pubmed/30186272
http://dx.doi.org/10.3389/fmicb.2018.01967
_version_ 1783350744314806272
author Ye, Jianzhong
Lv, Longxian
Wu, Wenrui
Li, Yating
Shi, Ding
Fang, Daiqiong
Guo, Feifei
Jiang, Huiyong
Yan, Ren
Ye, Wanchun
Li, Lanjuan
author_facet Ye, Jianzhong
Lv, Longxian
Wu, Wenrui
Li, Yating
Shi, Ding
Fang, Daiqiong
Guo, Feifei
Jiang, Huiyong
Yan, Ren
Ye, Wanchun
Li, Lanjuan
author_sort Ye, Jianzhong
collection PubMed
description Butyrate exerts protective effects against non-alcoholic steatohepatitis (NASH), but the underlying mechanisms are unclear. We aimed to investigate the role of butyrate-induced gut microbiota and metabolism in NASH development. Sixty-five C57BL/6J mice were divided into four groups (n = 15–17 per group) and were fed either a methionine–choline-sufficient (MCS) diet or methionine–choline-deficient (MCD) diet with or without sodium butyrate (SoB; 0.6 g/kg body weight) supplementation for 6 weeks. Liver injury, systematic inflammation, and gut barrier function were determined. Fecal microbiome and metabolome were analyzed using 16S rRNA deep sequencing and gas chromatography-mass spectrometry (GC-MS). The results showed that butyrate alleviated the MCD diet-induced microbiome dysbiosis, as evidenced by a significantly clustered configuration separate from that of the MCD group and by the depletion of Bilophila and Rikenellaceae and enrichment of promising probiotic genera Akkermansia, Roseburia, Coprococcus, Coprobacillus, Delftia, Sutterella, and Coriobacteriaceae genera. The fecal metabolomic profile was also substantially improved by butyrate; several butyrate-responsive metabolites involved in lipid metabolism and other pathways, such as stearic acid, behenic acid, oleic acid, linoleic acid, squalene, and arachidonic acid, were identified. Correlation analysis of the interaction matrix indicated that the modified gut microbiota and fecal metabolites induced by butyrate were strongly correlated with the alleviation of hepatic injury, fibrosis progression, inflammation, and lipid metabolism and intestinal barrier dysfunction. In conclusion, our results demonstrated that butyrate exerts protective effects against NASH development, and these effects may be driven by the protective gut microbiome and metabolome induced by butyrate. This study thus provides new insights into NASH prevention.
format Online
Article
Text
id pubmed-6111843
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61118432018-09-05 Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels Ye, Jianzhong Lv, Longxian Wu, Wenrui Li, Yating Shi, Ding Fang, Daiqiong Guo, Feifei Jiang, Huiyong Yan, Ren Ye, Wanchun Li, Lanjuan Front Microbiol Microbiology Butyrate exerts protective effects against non-alcoholic steatohepatitis (NASH), but the underlying mechanisms are unclear. We aimed to investigate the role of butyrate-induced gut microbiota and metabolism in NASH development. Sixty-five C57BL/6J mice were divided into four groups (n = 15–17 per group) and were fed either a methionine–choline-sufficient (MCS) diet or methionine–choline-deficient (MCD) diet with or without sodium butyrate (SoB; 0.6 g/kg body weight) supplementation for 6 weeks. Liver injury, systematic inflammation, and gut barrier function were determined. Fecal microbiome and metabolome were analyzed using 16S rRNA deep sequencing and gas chromatography-mass spectrometry (GC-MS). The results showed that butyrate alleviated the MCD diet-induced microbiome dysbiosis, as evidenced by a significantly clustered configuration separate from that of the MCD group and by the depletion of Bilophila and Rikenellaceae and enrichment of promising probiotic genera Akkermansia, Roseburia, Coprococcus, Coprobacillus, Delftia, Sutterella, and Coriobacteriaceae genera. The fecal metabolomic profile was also substantially improved by butyrate; several butyrate-responsive metabolites involved in lipid metabolism and other pathways, such as stearic acid, behenic acid, oleic acid, linoleic acid, squalene, and arachidonic acid, were identified. Correlation analysis of the interaction matrix indicated that the modified gut microbiota and fecal metabolites induced by butyrate were strongly correlated with the alleviation of hepatic injury, fibrosis progression, inflammation, and lipid metabolism and intestinal barrier dysfunction. In conclusion, our results demonstrated that butyrate exerts protective effects against NASH development, and these effects may be driven by the protective gut microbiome and metabolome induced by butyrate. This study thus provides new insights into NASH prevention. Frontiers Media S.A. 2018-08-21 /pmc/articles/PMC6111843/ /pubmed/30186272 http://dx.doi.org/10.3389/fmicb.2018.01967 Text en Copyright © 2018 Ye, Lv, Wu, Li, Shi, Fang, Guo, Jiang, Yan, Ye and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Ye, Jianzhong
Lv, Longxian
Wu, Wenrui
Li, Yating
Shi, Ding
Fang, Daiqiong
Guo, Feifei
Jiang, Huiyong
Yan, Ren
Ye, Wanchun
Li, Lanjuan
Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
title Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
title_full Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
title_fullStr Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
title_full_unstemmed Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
title_short Butyrate Protects Mice Against Methionine–Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
title_sort butyrate protects mice against methionine–choline-deficient diet-induced non-alcoholic steatohepatitis by improving gut barrier function, attenuating inflammation and reducing endotoxin levels
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111843/
https://www.ncbi.nlm.nih.gov/pubmed/30186272
http://dx.doi.org/10.3389/fmicb.2018.01967
work_keys_str_mv AT yejianzhong butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT lvlongxian butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT wuwenrui butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT liyating butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT shiding butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT fangdaiqiong butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT guofeifei butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT jianghuiyong butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT yanren butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT yewanchun butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels
AT lilanjuan butyrateprotectsmiceagainstmethioninecholinedeficientdietinducednonalcoholicsteatohepatitisbyimprovinggutbarrierfunctionattenuatinginflammationandreducingendotoxinlevels